bpc 157 subcutaneous dosing BPC-157 (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Peptide - Hormone Replacement
Description
2024;10:S0749-8063(24)00667-S0749-8063(24)00674

Age, genetics, metabolic health, and prior fertility history alter how an individual responds

Vattino L

It is also produced at extra-gonadal sites including adipose tissue, skin, osteoblasts, osteoclasts, aorta, and the brain

If their levels dont rise to a significant enough degree, they might have a growth hormone deficiency
